India's Pharma Industry to Hit $65B by 2024, Set to Double by 2030

India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030. CPHI & P-MEC India exemplifies this growth by connecting global and domestic stakeholders to showcase advancements in pharmaceutical machinery, technology, and ingredients. This year, the expo offers a pivotal marketplace for over 2000 exhibitors to engage, with anticipated participation from countries including the USA, UAE, South Korea, Japan, Egypt, Vietnam, the Philippines, Malaysia, Italy, Sri Lanka, Bangladesh, Nepal, Iran, and the United Kingdom.

This year, the expo maintains significant backing from major industry associations like CIPI, FOPE (Federation of Pharma Entrepreneurs), IPEC India, and Pharmexcil, reinforcing its status as the industry's most promising event.

Highlighting the significance of this year’s CPHI & PMEC India Expo, Yogesh Mudras, Managing Director, Informa Markets in India, said, “India’s pharmaceutical industry, currently ranked third globally by production volume, has evolved into a thriving sector with a CAGR of 9.43% over the past nine years. Known for delivering high-quality, affordable medicines, India has earned its reputation as the ‘Pharmacy of the World.’ The Ministry’s ‘Strengthening of Pharmaceutical Industry (SPI)’ initiative, backed by Rs. 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality, and sustainability across pharma clusters and MSMEs nationwide. Over the last 16 years, CPHI & P-MEC India Expo has mirrored the industry’s vision and growth. Now, as a key part of the world’s largest global pharmaceutical community, it has transformed from a trade show into a robust platform for expanding business opportunities and delivering real-time industry insights, positioning us at the forefront of global pharmaceutical advancements.”